Most Direct-to-Consumer Drug Advertisements Do Not Adhere to FDA Guidelines
Few DTC drug advertisements fully adhere to FDA guidelines, overall quality of information provided is low and some market drugs off-label
Stay updated with breaking news from Off Label. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Few DTC drug advertisements fully adhere to FDA guidelines, overall quality of information provided is low and some market drugs off-label
There is accumulating evidence that taking SSRI antidepressants increases the risk of bleeding and other complications during surgery
Shots because sign me up. >> yeah, the date that a lot of people are talking about right now is halloween, but that all depends on how quickly pfizer gets that application in and they said they plan to start doing that by the end of this month and then how long the fda takes to review it. there have been differing reports about how long that could be from as short as three weeks which would be really fast to perhaps four to six weeks. we will just have to see how long all of that deliberation takes, but scott gottlieb who is on the board of pfizer, former fda commissioner this morning on cnbc ...
Is isn't a public health problem anymore, it's a communication and a political problem at this point. >> dr. khan, we know now that pfizer has received this full fda approval that physicians, pediatricians can, technically, give this to children under 12. off-label. what's the advice. i know that the american association of pediatrics comes out with advice for doctors potentially giving it to young children, and we know parents really want that protection for their children. >> so, victor, and what -- this is true for all drugs that a physician can use off-label. but as a pediatrician, also, i...
>> and eva pilgrim with us tonight. and eva, we should point out that with this full approval of the pfizer vaccine, the fda still warning that the vaccine should not be used in younger children around 12, but that they're still working on this? >> reporter: that's right, david. the fda making it very clear that the vaccine should not be given off-label to children under 12. the commissioner saying they are not just small adults. the fda is still studying the safety data and the proper dose before making that reck m recommendation for those younger children. that decision could come this fall....